A5031898772- Acute Ischemic Stroke Management
- Vaccine Coverage and Hesitancy
- Atrial Fibrillation Management and Outcomes
- Cerebrovascular and Carotid Artery Diseases
- COVID-19 Pandemic Impacts
- Neurological Disorders and Treatments
- Artificial Intelligence in Healthcare and Education
- COVID-19 epidemiological studies
- Ethics in Clinical Research
- Viral gastroenteritis research and epidemiology
- Animal Virus Infections Studies
- SARS-CoV-2 and COVID-19 Research
- Misinformation and Its Impacts
- Artificial Intelligence in Healthcare
- COVID-19 and Mental Health
- Neurological and metabolic disorders
- Healthcare Systems and Practices
Clalit Health Services
2020-2024
Ben-Gurion University of the Negev
2021
Preapproval trials showed that messenger RNA (mRNA)-based vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety profile, yet these were subject to size and patient-mix limitations. An evaluation of the BNT162b2 mRNA vaccine with respect broad range potential adverse events is needed.We used data from largest health care organization in Israel evaluate vaccine. For each event, population persons no previous diagnosis we individually matched vaccinated...
Regulatory bodies are struggling to determine effective ways regulate artificial intelligence (AI)-driven health care solutions, which repeatedly exhibit suboptimal performance and unexpected outcomes when used in new settings. Existing evaluation frameworks typically structured as textual discussions that difficult translate into practical assessments of AI solutions often fail consider the perspectives specific populations data a designated deployment setting. Health organizations, faced...
As several countries now confront COVID-19 surges, Israel may be crossing over to other side of the pandemic. Whereas 5.5 million new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were reported globally last week, only 398 (compared with >50,000 in January). Already, 54% Israel's 9.2 citizens have been fully vaccinated, considerably more than most countries. In coming months, as restrictions continue ease, country should optimistic, yet cautious, risks resurgence...
The current paper clarifies the value of two methods to encourage COVID-19 vaccination: Simple nudge reminders, and regulation that increases benefit from vaccination. Our analysis reminders is based on a controlled experiment. results reveal in context reminder emphasizes personal 9% more effective than social nudge. regulations can be described as case study. It suggests green pass policy implemented Israel February 21, 2021 (and relaxes distance constraints for vaccinated individuals) was...
Inducing people to get vaccinated is critical for controlling the spread of COVID-19. We explored effectiveness two text messaging strategies encouraging unvaccinated individuals their COVID-19 vaccination. One message emphasized social norms harness people's tendency act in ways that line up with society's expectations. The other underscored personal medical benefits Both messages indicated vaccine was reserved recipient at a nearby location. Over course eight days, percentage who got after...
Abstract Funding Acknowledgements Pfizer Israel Background Diabetes mellitus (DM) is associated with increased risk of embolic complications in non-valvular atrial fibrillation (NVAF). Whether the stroke AF patients remains same among wide spectrum disease yet to be determined. Aim Among individuals and DM, assess incidence rates ischemic mortality by baseline HbA1C levels. Methods We conducted a prospective, historical cohort study using Clalit Health Services (CHS) electronic medical...
Abstract Funding Acknowledgements Pfizer pharmaceutical corporation Background Diabetes is a known risk factor for thromboembolic events in patients with non-valvular atrial fibrillation (NVAF). Whether on insulin therapy are at an increased stroke compered to treated solely by oral antidiabetic medications not yet established. Aim To assess the of ischemic and mortality NVAF diabetes mellitus (DM) vs. treatment. Methods A prospective, historical cohort study based Clalit Health Services...
Abstract Funding Acknowledgements Pfizer Israel Background Diabetes mellitus is a well-established independent risk factor for embolic complications in patients with non-valvular atrial fibrillation (NVAF). The association between prediabetes and of ischemic stroke, however, has not been studied separately NVAF. Purpose To evaluate whether pre-diabetes associated increased stroke death NVAF Methods We conducted prospective, historical cohort study using the Clalit Health Services (CHS)...
Abstract Funding Acknowledgements pfizer Background Diabetes mellitus (DM) is associated with increased risk of embolic complications in non-valvular atrial fibrillation (NVAF). Chronic kidney disease (CKD) has been shown some studies to increase the stroke. This finding not consistent among all studies. Therefore relationship between function, diabetes and stroke complex warrants further investigation. Purpose To assess incidence rates ischemic mortality by baseline Estimated Glomerular...